Updated airway clearance device adds lighter vest, wireless features
Written by |
Tactile Systems Technology has announced the commercial launch of a next-generation version of its AffloVest system, a high-frequency chest wall oscillation (HFCWO) device designed to help clear mucus from the airways in people with cystic fibrosis (CF) and other chronic respiratory or neuromuscular conditions.
“Commercial introduction of the next-generation AffloVest system reflects our ongoing commitment to innovation that improves the lives of patients who depend on our therapies every day, and we are pleased to make our upgraded airway clearance product available ahead of this year’s winter respiratory season,” said Sheri Dodd, Tactile’s CEO, in a company press release.
CF is a genetic disease in which the body produces abnormally thick and sticky mucus, which builds up in the lungs and other organs to drive most disease symptoms. A variety of treatments are available to help manage CF and its symptoms, but the buildup of mucus in the lungs and airways can still be a persistent problem for many people with CF.
HFCWO systems such as AffloVest generally use a vest worn over the torso that vibrates the chest wall. These vibrations can help loosen mucus, making it easier to cough up and clear from the airways. These systems are commonly used by people with CF and a range of other respiratory and neuromuscular conditions in which airway mucus buildup can cause problems.
The next-generation version of the AffloVest was designed with input from patients, clinicians, and durable medical equipment partners, with the overall goal of making the system simpler to use and more comfortable. Among the improvements, the new system uses a vest that is lighter and more adjustable than its earlier version, aiming to make it less cumbersome to wear and easier to accommodate a wide range of body types. The updated vest is paired with a redesigned controller that aims to be more intuitive, making the system easier to set up and use.
The next-generation AffloVest also offers built-in Wi-Fi and Bluetooth connectivity, allowing patients to view their treatment progress and clinicians to use real-world data in more informed, personalized treatment discussions. Durable medical equipment providers also can access therapy utilization data to support patient care and reimbursement requirements with payers.
“Importantly, the new system preserves the same proven clinical foundation that clinicians trust, while delivering a more comfortable and connected experience, reinforcing AffloVest’s position as a versatile solution for chronic respiratory patients,” Dodd said. “We designed this new system with the entire care network in mind, from the patient managing their condition to the clinician guiding their care.”
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.
Get regular updates to your inbox.
3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363
This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2026 All rights reserved.
Don’t have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.
Leave a Reply